Report Categories
View AllRecent Articles
View All
CZFS Q1 2026 Earnings EPS Beats Estimates by Nearly 7 But Stock Slips
PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction
Damora Therapeutics Q1 2026 Earnings WiderThanExpected Loss Despite Stock Gain
JCAP Q1 2026 Earnings EPS Surprise Lifts Expectations Amid Narrow Revenue Disclosures
MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline